<div class="card-header text-white fs-5" style="background-color: #E0881B;">
    <div class="headertext">
        <div class="Litigationfirst d-flex align-items-center">
            <i class="fa-solid fa-flask me-2"></i>
            <span>SPC Database >> SITAGLIPTIN PHOSPHATE</span>
        </div>

        <div class="LitigationSecond d-flex align-items-center">
            <select class="select text-black me-3">
                <option>All Country</option>
                <option>Austria (9)</option>
                <option>Belgium (5)</option>
                <option>Denmark (10)</option>
                <option>Estonia (9)</option>
                <option>Finland (13)</option>
                <option>France (38)</option>
                <option>Germany (9)</option>
                <option>Ireland (10)</option>
                <option>Italy (5)</option>
                <option>Lithuania (16)</option>
                <option>Luxembourg (6)</option>
                <option>Netherlands (9)</option>
                <option>Romania (1)</option>
                <option>Slovakia (7)</option>
                <option>Spain (2)</option>
                <option>Sweden (16)</option>
                <option>Switzerland (23)</option>
                <option>United Kingdom (12)</option>
            </select>
        </div>
        <div class="totalreward">
            <p class="totalRecords mb-0 me-3">Total Records: <b>1884</b></p>
            
        </div>
        <i class="fa-solid fa-download"></i>
    </div>
</div>

<div class="table-container">
    <table>
        <thead>
            <tr>
                <th>GREEN BOOK REGISTRATION <br>NUMBER(GBRN)</th>
                <th>PRODUCT</th>
                <th>Product Search Key</th>
                <th>Country</th>
                <th>SPC Number</th>
                <th>SPC Filing Date</th>
                <th>Product Type Name</th>
                <th>Applicant Name</th>
                <th>Publication Number</th>
                <th>Patent Family Equivalents</th>
                <th>Indian Patent Equivalents</th>
                <th>Title</th>
                <th>UK Authority Date</th>
                <th>Earliest Authority Date</th>
                <th>SPC Grant Date</th>
                <th>Actual Expiry Date</th>
                <th>Date of Expiry SPC</th>
                <th>Extenstion Expiry Date</th>
                <th>Entry into Force Date</th>
                <th>Patent Filing Date</th>
                <th>Patent Grant Date</th>
                <th>Date of Expiry of Patent</th>
                <th>Patent Status</th>
                <th>Description</th>
                <th>Date Protection Date</th>
                <th>REMARKS(S)</th>
                <th>Event Date</th>
            </tr>
        </thead>
        <tbody>
            <tr style="background-color: #ECECE8;">
                <td>10267;10227;10185;18285;19853;10313</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>Switzerland</td>
                <td>C01084705/02</td>
                <td>NA</td>
                <td>Pharmaceutical</td>
                <td>Royalty Pharma Collection TRUST</td> 

                <td>EP1084705<br>
                <a style="color: red;" href="https://worldwide.espacenet.com/patent/search/family/007792391/publication/EP1084705A2?q=EP1084705"> Espacenet Patent Search </a><br>
                <a href="https://patents.google.com/patent/EP1084705" style="color: blue;"> Google Patent Search </a>
                </td>

                <td> Patent Information:<br>

                    1. Patent Number: EP1084705B1 (WO9740832A1)
                    Assignee: Probiodrug AG; Prosidion Ltd; Royalty Pharma Finance Trust; Royalty Pharma Collection Trust
                    Publication Date: 2001-03-21
                    Est. ...</td>
                <td>Not Found</td>
                <td>Method for Lowering blood glucose levels in mammals</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
               
                <td>2017-04-24</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>1997-04-24</td>
                <td>2014-06-25</td>
                <td>2017-04-24</td>
                <td>Granted</td>
                <td> Active Ingredient: 
                    SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALO ...<br>
                    <button (click)="openPopup2()" class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
                        Read More
                         </button>
                         <div *ngIf="isPopupOpen2" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
                             <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                               <h2 class="text-lg font-bold">Description</h2>
                               <button (click)="closePopup2()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>

                               <br>
                               <hr>
                             <p class="mt-2"> 
                                Active Ingredient: <br>
                                SITAGLIPTIN + METFORMIN<br>
                                Patent Number: <br>
                                EP1412357<br><br>
                                
                                Patentee: <br>
                                Applicant Name: <br>
                                Event date: <br>
                                29.11.2012<br>
                                
                                Country: <br>
                                Germany<br>
                                Event Description: <br>
                                REFERENCE TO A NATIONAL CODE<br><br>
                                
                                Event Code: <br>
                                REG DE R069<br><br>
                                
                                Code Expl.: <br>
                                +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED<br><br>
                                
                                Free Format Text: <br>
                                PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE SITAGLIPTINPHOSPHAT- MONOHYDRAT, IN KOMBINATION MIT METFORMIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 FIRST REGISTRATION: CH/LI 58450 01 58450 02 58450 03 20080408<br>
                                
                                Supplementary Protection Certificate (SPC) Number: <br>
                                122008000046<br>
                                
                                Filing Date: <br>
                                20080911<br><br>
                                
                                Extension Date: <br>
                                20230408<br><br>
                                
                                Effective Date: <br>
                                20120825<br><br>
                             </p>
                             <!-- Close Button -->
                             <button (click)="closePopup2()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                           </div>
                           </div>
                </td>
                <td>N/A</td>
                
                <td>Source: European Patent Register - https://register.epo.org/</td>
                <td>2014-12-31</td>
                
            </tr>

            <tr style="background-color: #F9F9F4">
                <td>10267;10227;10185;18285;19853;10313</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>Switzerland</td>
                <td>C01084705/02</td>
                <td>NA</td>
                <td>Pharmaceutical</td>
                <td>Royalty Pharma Collection TRUST</td> 

                <td>EP1084705<br>
                    <a style="color: red;" href="https://worldwide.espacenet.com/patent/search/family/007792391/publication/EP1084705A2?q=EP1084705"> Espacenet Patent Search </a><br>
                    <a href="https://patents.google.com/patent/EP1084705" style="color: blue;"> Google Patent Search </a>
                    </td>

                <td> Patent Information:<br>

                    1. Patent Number: EP1084705B1 (WO9740832A1)
                    Assignee: Probiodrug AG; Prosidion Ltd; Royalty Pharma Finance Trust; Royalty Pharma Collection Trust
                    Publication Date: 2001-03-21
                    Est. ...</td>
                <td>Not Found</td>
                <td>Method for Lowering blood glucose levels in mammals</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
               
                <td>2017-04-24</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>1997-04-24</td>
                <td>2014-06-25</td>
                <td>2017-04-24</td>
                <td>Granted</td>
                <td> Active Ingredient: 
                    SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALO ...<br>
                    <button (click)="openPopup()" class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
                       Read More
                        </button>
                        <div *ngIf="isPopupOpen" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
                            <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                              <h2 class="text-lg font-bold">Description</h2>
                              <button (click)="closePopup()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>

                              <br>
                              <hr>
                            <p class="mt-2"> 
                                Active Ingredient: <br>
                                SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN <br>
                               Patent Number: <br>
                               EP1084705<br><br>
                               
                               Patentee: <br>
                               Applicant Name: <br>
                               Event date: <br>
                               29.04.2022<br><br>
                               
                               Country: <br>
                               Switzerland<br>
                               Event Description: <br>
                               REFERENCE TO A NATIONAL CODE<br><br>
                               
                               Event Code: <br>
                               REG CH SPCL<br><br>
                               
                               Code Expl.: <br>
                               -SUPPLEMENTARY PROTECTION CERTIFICATE DELETION<br><br>
                               
                               Supplementary Protection Certificate (SPC) Number: <br>
                               C01084705/01<br><br>
                            </p>
                            <!-- Close Button -->
                            <button (click)="closePopup()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                          </div>
                          </div>
                
                </td>
                <td>N/A</td>
                
                <td>Source: European Patent Register - https://register.epo.org/</td>
                <td>2014-12-31</td>
                
            </tr>

            <!-- ========================3rd and 4th============================= -->
            <tr style="background-color: #ECECE8;">
                <td>10267;10227;10185;18285;19853;10313</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>Switzerland</td>
                <td>C01084705/02</td>
                <td>NA</td>
                <td>Pharmaceutical</td>
                <td>Royalty Pharma Collection TRUST</td> 

                <td>EP1084705<br>
                <a style="color: red;" href="https://worldwide.espacenet.com/patent/search/family/007792391/publication/EP1084705A2?q=EP1084705"> Espacenet Patent Search </a><br>
                <a href="https://patents.google.com/patent/EP1084705" style="color: blue;"> Google Patent Search </a>
                </td>

                <td> Patent Information:<br>

                    1. Patent Number: EP1084705B1 (WO9740832A1)
                    Assignee: Probiodrug AG; Prosidion Ltd; Royalty Pharma Finance Trust; Royalty Pharma Collection Trust
                    Publication Date: 2001-03-21
                    Est. ...</td>
                <td>Not Found</td>
                <td>Method for Lowering blood glucose levels in mammals</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
               
                <td>2017-04-24</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>1997-04-24</td>
                <td>2014-06-25</td>
                <td>2017-04-24</td>
                <td>Granted</td>
                <td> Active Ingredient: 
                    SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALO ...<br>
                    <button (click)="openPopup2()" class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
                        Read More
                         </button>
                         <div *ngIf="isPopupOpen2" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
                             <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                               <h2 class="text-lg font-bold">Description</h2>
                               <button (click)="closePopup2()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>

                               <br>
                               <hr>
                             <p class="mt-2"> 
                                Active Ingredient: <br>
                                SITAGLIPTIN + METFORMIN<br>
                                Patent Number: <br>
                                EP1412357<br><br>
                                
                                Patentee: <br>
                                Applicant Name: <br>
                                Event date: <br>
                                29.11.2012<br>
                                
                                Country: <br>
                                Germany<br>
                                Event Description: <br>
                                REFERENCE TO A NATIONAL CODE<br><br>
                                
                                Event Code: <br>
                                REG DE R069<br><br>
                                
                                Code Expl.: <br>
                                +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED<br><br>
                                
                                Free Format Text: <br>
                                PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE SITAGLIPTINPHOSPHAT- MONOHYDRAT, IN KOMBINATION MIT METFORMIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 FIRST REGISTRATION: CH/LI 58450 01 58450 02 58450 03 20080408<br>
                                
                                Supplementary Protection Certificate (SPC) Number: <br>
                                122008000046<br>
                                
                                Filing Date: <br>
                                20080911<br><br>
                                
                                Extension Date: <br>
                                20230408<br><br>
                                
                                Effective Date: <br>
                                20120825<br><br>
                             </p>
                             <!-- Close Button -->
                             <button (click)="closePopup2()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                           </div>
                           </div>
                </td>
                <td>N/A</td>
                
                <td>Source: European Patent Register - https://register.epo.org/</td>
                <td>2014-12-31</td>
                
            </tr>

            <tr style="background-color: #F9F9F4">
                <td>10267;10227;10185;18285;19853;10313</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>Switzerland</td>
                <td>C01084705/02</td>
                <td>NA</td>
                <td>Pharmaceutical</td>
                <td>Royalty Pharma Collection TRUST</td> 

                <td>EP1084705<br>
                    <a style="color: red;" href="https://worldwide.espacenet.com/patent/search/family/007792391/publication/EP1084705A2?q=EP1084705"> Espacenet Patent Search </a><br>
                    <a href="https://patents.google.com/patent/EP1084705" style="color: blue;"> Google Patent Search </a>
                    </td>

                <td> Patent Information:<br>

                    1. Patent Number: EP1084705B1 (WO9740832A1)
                    Assignee: Probiodrug AG; Prosidion Ltd; Royalty Pharma Finance Trust; Royalty Pharma Collection Trust
                    Publication Date: 2001-03-21
                    Est. ...</td>
                <td>Not Found</td>
                <td>Method for Lowering blood glucose levels in mammals</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
               
                <td>2017-04-24</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>1997-04-24</td>
                <td>2014-06-25</td>
                <td>2017-04-24</td>
                <td>Granted</td>
                <td> Active Ingredient: 
                    SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALO ...<br>
                    <button (click)="openPopup()" class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
                       Read More
                        </button>
                        <div *ngIf="isPopupOpen" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
                            <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                              <h2 class="text-lg font-bold">Description</h2>
                              <button (click)="closePopup()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>

                              <br>
                              <hr>
                            <p class="mt-2"> 
                                Active Ingredient: <br>
                                SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN <br>
                               Patent Number: <br>
                               EP1084705<br><br>
                               
                               Patentee: <br>
                               Applicant Name: <br>
                               Event date: <br>
                               29.04.2022<br><br>
                               
                               Country: <br>
                               Switzerland<br>
                               Event Description: <br>
                               REFERENCE TO A NATIONAL CODE<br><br>
                               
                               Event Code: <br>
                               REG CH SPCL<br><br>
                               
                               Code Expl.: <br>
                               -SUPPLEMENTARY PROTECTION CERTIFICATE DELETION<br><br>
                               
                               Supplementary Protection Certificate (SPC) Number: <br>
                               C01084705/01<br><br>
                            </p>
                            <!-- Close Button -->
                            <button (click)="closePopup()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                          </div>
                          </div>
                
                </td>
                <td>N/A</td>
                
                <td>Source: European Patent Register - https://register.epo.org/</td>
                <td>2014-12-31</td>
                
            </tr>
            <!-- ===========================5th and 6th============================ -->
            <tr style="background-color: #ECECE8;">
                <td>10267;10227;10185;18285;19853;10313</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>Switzerland</td>
                <td>C01084705/02</td>
                <td>NA</td>
                <td>Pharmaceutical</td>
                <td>Royalty Pharma Collection TRUST</td> 

                <td>EP1084705<br>
                <a style="color: red;" href="https://worldwide.espacenet.com/patent/search/family/007792391/publication/EP1084705A2?q=EP1084705"> Espacenet Patent Search </a><br>
                <a href="https://patents.google.com/patent/EP1084705" style="color: blue;"> Google Patent Search </a>
                </td>

                <td> Patent Information:<br>

                    1. Patent Number: EP1084705B1 (WO9740832A1)
                    Assignee: Probiodrug AG; Prosidion Ltd; Royalty Pharma Finance Trust; Royalty Pharma Collection Trust
                    Publication Date: 2001-03-21
                    Est. ...</td>
                <td>Not Found</td>
                <td>Method for Lowering blood glucose levels in mammals</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
               
                <td>2017-04-24</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>1997-04-24</td>
                <td>2014-06-25</td>
                <td>2017-04-24</td>
                <td>Granted</td>
                <td> Active Ingredient: 
                    SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALO ...<br>
                    <button (click)="openPopup2()" class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
                        Read More
                         </button>
                         <div *ngIf="isPopupOpen2" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
                             <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                               <h2 class="text-lg font-bold">Description</h2>
                               <button (click)="closePopup2()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>

                               <br>
                               <hr>
                             <p class="mt-2"> 
                                Active Ingredient: <br>
                                SITAGLIPTIN + METFORMIN<br>
                                Patent Number: <br>
                                EP1412357<br><br>
                                
                                Patentee: <br>
                                Applicant Name: <br>
                                Event date: <br>
                                29.11.2012<br>
                                
                                Country: <br>
                                Germany<br>
                                Event Description: <br>
                                REFERENCE TO A NATIONAL CODE<br><br>
                                
                                Event Code: <br>
                                REG DE R069<br><br>
                                
                                Code Expl.: <br>
                                +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED<br><br>
                                
                                Free Format Text: <br>
                                PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE SITAGLIPTINPHOSPHAT- MONOHYDRAT, IN KOMBINATION MIT METFORMIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 FIRST REGISTRATION: CH/LI 58450 01 58450 02 58450 03 20080408<br>
                                
                                Supplementary Protection Certificate (SPC) Number: <br>
                                122008000046<br>
                                
                                Filing Date: <br>
                                20080911<br><br>
                                
                                Extension Date: <br>
                                20230408<br><br>
                                
                                Effective Date: <br>
                                20120825<br><br>
                             </p>
                             <!-- Close Button -->
                             <button (click)="closePopup2()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                           </div>
                           </div>
                </td>
                <td>N/A</td>
                
                <td>Source: European Patent Register - https://register.epo.org/</td>
                <td>2014-12-31</td>
                
            </tr>

            <tr style="background-color: #F9F9F4">
                <td>10267;10227;10185;18285;19853;10313</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN</td>
                <td>Switzerland</td>
                <td>C01084705/02</td>
                <td>NA</td>
                <td>Pharmaceutical</td>
                <td>Royalty Pharma Collection TRUST</td> 

                <td>EP1084705<br>
                    <a style="color: red;" href="https://worldwide.espacenet.com/patent/search/family/007792391/publication/EP1084705A2?q=EP1084705"> Espacenet Patent Search </a><br>
                    <a href="https://patents.google.com/patent/EP1084705" style="color: blue;"> Google Patent Search </a>
                    </td>

                <td> Patent Information:<br>

                    1. Patent Number: EP1084705B1 (WO9740832A1)
                    Assignee: Probiodrug AG; Prosidion Ltd; Royalty Pharma Finance Trust; Royalty Pharma Collection Trust
                    Publication Date: 2001-03-21
                    Est. ...</td>
                <td>Not Found</td>
                <td>Method for Lowering blood glucose levels in mammals</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
               
                <td>2017-04-24</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>N/A</td>
                <td>1997-04-24</td>
                <td>2014-06-25</td>
                <td>2017-04-24</td>
                <td>Granted</td>
                <td> Active Ingredient: 
                    SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALO ...<br>
                    <button (click)="openPopup()" class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
                       Read More
                        </button>
                        <div *ngIf="isPopupOpen" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
                            <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                              <h2 class="text-lg font-bold">Description</h2>
                              <button (click)="closePopup()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>

                              <br>
                              <hr>
                            <p class="mt-2"> 
                                Active Ingredient: <br>
                                SAXAGLIPTIN; LINAGLIPTIN; ALOGLIPTIN; VILDAGLIPTIN; SITAGLIPTIN; BENZOATE D'ALOGLIPTIN <br>
                               Patent Number: <br>
                               EP1084705<br><br>
                               
                               Patentee: <br>
                               Applicant Name: <br>
                               Event date: <br>
                               29.04.2022<br><br>
                               
                               Country: <br>
                               Switzerland<br>
                               Event Description: <br>
                               REFERENCE TO A NATIONAL CODE<br><br>
                               
                               Event Code: <br>
                               REG CH SPCL<br><br>
                               
                               Code Expl.: <br>
                               -SUPPLEMENTARY PROTECTION CERTIFICATE DELETION<br><br>
                               
                               Supplementary Protection Certificate (SPC) Number: <br>
                               C01084705/01<br><br>
                            </p>
                          
                            <button (click)="closePopup()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                          </div>
                          </div>
                
                </td>
                <td>N/A</td>
                
                <td>Source: European Patent Register - https://register.epo.org/</td>
                <td>2014-12-31</td>
                
            </tr>
        </tbody>
    </table>
</div>
